Integer Holdings (ITGR) Research & Development (2010 - 2026)
Integer Holdings (ITGR) reported Research & Development of $16.2 million for Q2 2026, up 14.38% on a YoY basis from $14.2 million in Q2 2025, and up 60.68% sequentially from $10.1 million in Q4 2025.
Integer Holdings (ITGR) Research & Development (2010 - 2026) Analysis & Trends
Integer Holdings (ITGR) has 17 years of Research & Development data on file, last reported at $16.2 million in Q2 2026.
- For the quarter ending Q2 2026, Research & Development rose 14.38% year-over-year to $16.2 million; the trailing twelve-month figure through Apr 2026 stood at $51.5 million (down 1.55% YoY), and the FY2025 full-year result was $49.5 million, down 7.35% from the prior year.
- Research & Development climbed to $16.2 million in Q2 2026, from $10.1 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $19.1 million in Q1 2023 to a low of $10.1 million in Q4 2025.
- A 5-year average of $14.2 million and a median of $14.2 million in 2025 frame the typical range for Research & Development.
- Across the five-year window, Research & Development soared 33.8% in 2022 and slipped 20.0% in 2024, its largest moves.
- Tracing ITGR's Research & Development over 5 years: stood at $12.7 million in 2022, then increased by 2.88% to $13.0 million in 2023, then decreased by 18.67% to $10.6 million in 2024, then dropped by 4.76% to $10.1 million in 2025, then soared by 60.68% to $16.2 million in 2026.
- Business Quant data shows ITGR's Research & Development at $16.2 million in Q2 2026, $10.1 million in Q4 2025, and $10.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Integer Holdings | 3.34 Bn | 3.33 Bn | 109.60 Mn | 16.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 16.24 Mn |
| Dec 31, 2025 | 10.11 Mn |
| Sep 26, 2025 | 10.95 Mn |
| Jun 27, 2025 | 14.24 Mn |
| Mar 28, 2025 | 14.20 Mn |
| Dec 31, 2024 | 10.61 Mn |
| Sep 27, 2024 | 11.92 Mn |
| Jun 28, 2024 | 15.61 Mn |
| Mar 29, 2024 | 15.27 Mn |
| Dec 31, 2023 | 13.05 Mn |
| Sep 29, 2023 | 14.07 Mn |
| Jun 30, 2023 | 16.88 Mn |
| Mar 31, 2023 | 19.09 Mn |
| Dec 31, 2022 | 12.69 Mn |
| Sep 30, 2022 | 16.12 Mn |
| Jul 1, 2022 | 14.87 Mn |
| Apr 1, 2022 | 16.08 Mn |
| Dec 31, 2021 | 12.74 Mn |
| Oct 1, 2021 | 12.05 Mn |
| Jul 2, 2021 | 13.74 Mn |